Navigation Links
Cystic Fibrosis Foundation Announces $5 Million Initiative to Enhance Care for Adults with CF - as Lifespan Increases
Date:3/18/2008

BETHESDA, Md., March 18 /PRNewswire-USNewswire/ -- The Cystic Fibrosis Foundation today announced the launch of a new $5 million initiative to enhance care for the growing adult CF population. The initiative, called the Program for Adult Care Excellence (PACE), will expand the scope of adult care programs for people with cystic fibrosis.

The number of adults with cystic fibrosis continues to increase as life expectancy for the disease continues to rise. To meet the growing demand for care, the Foundation will recruit and train CF care providers and fellows, with an overall goal of adding 40 new adult providers in care centers nationwide.

"The need for enhanced resources to treat the adult CF population is a direct result of our success in extending the life span of people with cystic fibrosis," said Preston W. Campbell, III, M.D., executive vice president for medical affairs of the Cystic Fibrosis Foundation. "What used to be a pediatric disease is now increasingly a chronic illness that brings its own set of challenges for adults."

In 1955, when the Foundation was established, children with CF rarely lived long enough to attend elementary school. Today, thanks to improvements in CF research and care, the median predicted age of survival is 37, and 43 percent of all people with cystic fibrosis are over the age of 18.

Over the past two decades the Foundation has made key investments in adult care to keep pace with the growing adult population. For example, in the 1980s, the Foundation began providing fellowships for internal medicine physicians to be trained in pulmonary medicine and CF care.

In 2000 the Foundation mandated that all care centers with more than 40 adult patients establish adult care programs. Today, there are 96 such programs in the country. This latest initiative is the most recent step in the Foundation's efforts to provide adult CF patients with the highest quality care.

"We are proud of
'/>"/>

SOURCE Cystic Fibrosis Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Newborn Screening Suggests Decline in Cystic Fibrosis
2. Bone complications due to cystic fibrosis have a genetic cause, according to an MUHC study
3. Drug fights cystic fibrosis
4. Secondhand Smoke Worsens Lung Function in Cystic Fibrosis Patients
5. Cystic Fibrosis Foundation reports upward trend for key health outcomes
6. Montana Passes Newborn Screening Law for Cystic Fibrosis
7. Ibuprofen Preserves Lung Function in Kids With Cystic Fibrosis
8. Ibuprofen associated with slower lung function decline in children with cystic fibrosis
9. Lung Transplants May Not Help Most Cystic Fibrosis Children
10. Experts Release New Cystic Fibrosis Guidelines
11. Cystic Fibrosis foundation lays out new treatment guidelines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... University of California, San Diego School of Medicine report ... peppers produces chronic activation of a receptor on ... that ultimately reduces the risk of colorectal tumors. , ... issue of The Journal of Clinical Investigation . ... originally discovered in sensory neurons, where it acts as ...
(Date:8/1/2014)... Barbara Bronson Gray HealthDay Reporter ... and work in manufacturing jobs may have significantly less endurance than ... study of 32 people -- half were obese, half were of ... that were about 60 percent longer. Obesity also was associated ... Being older -- 50 to 65 years of age ...
(Date:8/1/2014)... In a first-of-its-kind study, researchers at University Hospitals Rainbow ... infants may be at greater risk for death on ... emergencies on flights worldwide between January 2010 and June ... children under the age of 2. , The ... the rare event of an in-flight pediatric fatality onboard ...
(Date:8/1/2014)... As AndroGel lawsuits and testosterone lawsuits ... Johnson, Jr. has been appointed as co-lead counsel to ... medications. Since the Fall of 2013, Ron and his ... to investigate and prosecute the claims of men who ... as a result of taking testosterone. As a result ...
(Date:8/1/2014)... Growing prevalence of chronic ailments, ... are boosting healthcare market growth, although a reduction ... increasing generic consumption is a major challenge. , ... 2013, having grown at a Compound Annual Growth ... of the Health Transformation Program (Saglikta Donus, um ...
Breaking Medicine News(10 mins):Health News:Pepper and halt: Spicy chemical may inhibit gut tumors 2Health News:Obesity Might Slow You Down at Work 2Health News:Obesity Might Slow You Down at Work 3Health News:New research characterizes in-flight pediatric deaths 2Health News:Ron Johnson Named Co-Lead Counsel in Lawsuits for Men Injured by AndroGel and Testosterone 2Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 2Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 3Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 4
... PHILADELPHIA Scientists believe they have identified a role for ... from UVB radiation, a known risk factor for non-melanoma skin ... , a journal of the American Association for Cancer Research. ... at the University of Chicago, found that laboratory mice with ...
... School of Public Health (HSPH) has been awarded a ... Gates Foundation to test the effectiveness of an innovative ... outcomes of mothers and infants in 120 hospitals in ... Organization (WHO) and HSPH. Atul Gawande, associate professor in ...
... 2011 Adding hormone therapy to radiation therapy has ... survival for men with intermediate- and high-risk prostate cancer. ... men with pre-existing heart conditions, even if they have ... published online in advance of print in the ...
... for returning veterans may include addictions, injury and the ... a University of Houston joint study funded by the ... to address these issues through the use of virtual ... Work (GCSW) joins Baylor College of Medicine and the ...
... People who abused methamphetamine or other amphetamine-like stimulants were ... did not, in a new study from the Centre ... examined almost 300,000 hospital records from California covering 16 ... disorders had a 76 per cent higher risk of ...
... ROCKVILLE, MD, USA/BEIJING, CHINA, July 26, 2011 Aeras and ... of a memorandum of understanding for the organizations to pursue ... potentially other parts of the world. The partnership ... development of TB vaccines. TB is a major public ...
Cached Medicine News:Health News:Harvard School of Public Health receives $14.1 million to test childbirth checklist 2Health News:Harvard School of Public Health receives $14.1 million to test childbirth checklist 3Health News:Hormone therapy may be hazardous for men with heart conditions 2Health News:Returning vets' alcohol abuse addressed in virtual reality study 2Health News:Increased risk of Parkinson's disease in methamphetamine users, CAMH study finds 2Health News:Aeras and China National Biotech Group sign memorandum of understanding for TB vaccine R&D 2
(Date:8/1/2014)... CHICAGO , Ill. and PALO ALTO, ... ABBV) and Cystic Fibrosis Research, Inc. (CFRI) today announced a ... the cystic fibrosis (CF) community through the CFChef Shares ... September 15, 2014, as part of AbbVie,s CFChef program ... – to encourage patients to maintain a healthy diet ...
(Date:8/1/2014)... Aug. 1, 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ... pivotal Phase 3 study evaluating ISIS-SMN Rx in ... genetic cause of infant mortality. Isis plans to dose ... few weeks, at which time Isis will earn an ... Idec. The Phase 3 study, ENDEAR, is the first ...
(Date:8/1/2014)... Aug. 1, 2014 Arena Pharmaceuticals, Inc. ... corporate update and reported financial results for the ... "We have continued to see encouraging advancements ... 43% quarter-over-quarter increase in estimated total prescriptions and ... mark," said Jack Lief, Arena,s President and Chief ...
Breaking Medicine Technology:AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 3Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 2Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 3Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 4Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 5Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 2Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 3Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 4Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 5Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 6Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 7Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 8Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 9Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 10Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 11
... Ala., May 7 BioCryst Pharmaceuticals (Nasdaq: BCRX ... first quarter 2009 financial results will be released on Friday, ... a conference call and Web cast at 8:30 a.m. Eastern ... on the Company,s programs. The call will be led ...
... The Abbott RealTi m e HIV-1 Assay and Abbott ... protocol for viral load testing in HIV/AIDS clinical trials sponsored ... This recommendation was made by the Cross-Network Laboratory Focus Group ... HIV/AIDS clinical trials networks. The LFG recently issued a consensus ...
Cached Medicine Technology:BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009 2HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials 2HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials 3
... stapler is a full-feature skin stapler with ... RH has improved visibility over existing fixed-head ... mechanism for easier staple placement., ,This ... use instrument designed to deliver rectangular, stainless ...
... linear stapler with LACTOMER™ 9-1 ... is a copolymer of glycolide ... Suture™ ROTICULATOR 55 POLY™ single ... use in abdominal, gynecologic, pediatric ...
... Loading Units With Titanium Staples ... TA™ (Single Use Reloadable Stapler ... Auto Suture™ PREMIUM MULTIFIRE TA™ ... gynecological, pediatric and thoracic surgical ...
... reloadable linear stapler for resection, transection and ... Suture™ MULTIFIRE GIA™ 60 and 80 single ... and 80 single use loading units and ... single use surgical stapler with MULTIFIRE SGIA™ ...
Medicine Products: